Tirzepatide 10mg
$150.00
Tirzepatide was developed to fight type 2 diabetes, but has additionally been shown to protect the cardiovascular system and act as a potent weight loss agent. Tirzepatide is a synthetic derivative of gastric inhibitory polypeptide (GIP) that has simultaneous glucagon-like peptide-1 (GLP-1) functionality as well. This combination allows Tirzepatide to lower blood glucose levels, increase insulin sensitivity, boost feelings of satiety, and accelerate weight loss.
Disclaimer
Please be aware that all products provided by MyPeptides are strictly meant for research purposes, and not intended for human consumption. Your purchase from MyPeptides signifies your understanding and acceptance of these conditions.
About This Product
- Glycemic Regulation: Tirzepatide acts as a potent agent to lower blood glucose levels, paving the way for optimized metabolic research.
- Increased Insulin Sensitivity: By enhancing insulin sensitivity, Tirzepatide facilitates the exploration of novel approaches in managing type 2 diabetes research.
- Promotion of Satiety: As a synthetic derivative of GIP with GLP-1 functionality, Tirzepatide offers researchers a unique tool to study the mechanisms of satiety and potential weight loss pathways.
- Cardiovascular Protection: Tirzepatide’s demonstrated cardiovascular protective properties broaden its scope in research, providing significant versatility extending beyond metabolic diseases.
- Weight Loss Acceleration: With potential weight loss attributes, Tirzepatide could illuminate the understanding of weight management and obesity research, expanding horizons for innovative solutions.
Please remember, our products, including Tirzepatide, are intended for research purposes only and not for human consumption.
Be The first to know
Unlock 10% off your first order! Subscribe to our newsletter for the latest in peptide research and exclusive offers. Don’t wait, subscribe now!